MyFinsight
Home
Blog
About
Contact
Short-term investments
$317,879K
Cash and cash
equivalents
$28,828K
Prepaid expenses and
other current assets
$5,743K
Accounts receivable
$646K
Total current assets
$353,096K
Operating lease
right-of-use asset
$2,264K
Restricted cash
$1,527K
Property and equipment,
net
$1,090K
Goodwill
$949K
Intangible assets, net
$401K
Other assets
$31K
Total assets
$359,358K
Total liabilities and
stockholders' equity
$359,358K
Total stockholders'
equity
$319,944K
Total liabilities
$39,414K
Accumulated deficit
-$730,197K
Additional paid-in capital
$1,050,037K
Total current
liabilities
$34,023K
Other long-term
liabilities
$4,412K
Deferred revenue, net of
current portion
$979K
Accumulated other
comprehensive income
$102K
Common stock
$2K
Deferred revenue,
current portion
$17,876K
Accrued liabilities
$11,923K
Operating lease
liabilities - short term
$2,856K
Accounts payable
$1,368K
Back
Back
Balance Sheet
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX)
source: myfinsight.com